Krebs Biochemicals And Industries Limited (KREBSBIO)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
112.45
4.9(4.56%)

Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products, such as androstenedione, lovastatin, and simvastatin for anti-cholesterol and steroid intermediate applications. The company is also developing various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is headquartered in Hyderabad, India.

Pricing Updates

TODAY'S HIGH

114.5

TODAY'S LOW

107.7

52 WEEK HIGH

227.9

52 WEEK LOW

97.7

Major Holders

% of Shares Held by
All Insider

77.55%

% of Shares Held by
Institutions

0.00%

% of Float Held by
Institutions

0.00%

Number of Institutions
Holding Shares

0

Company Overview

MARKET CAP

242.44 Cr.

ETERPRISE VALUE

382.06 Cr.

NO. OF SHARES

2.15 Cr.

BOOK VALUE

-35.775

DIV. YIELD

2.892983%

DEBT

142.91 Cr.

GROSS PROFIT

13.99 Cr.

CASH

10.06 Lakhs

REVENUE

63.58 Cr.

REVENUE/SHARE

29.463

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments0000
Change To Liabilities17.12 Cr.-1.87 Cr.1.25 Cr.3.78 Cr.
Total cashflows from Investing Activities-22.89 Cr.-22.54 Cr.-10.22 Cr.-4.31 Cr.
Net Borrowings32.38 Cr.33.49 Cr.15.06 Cr.-1.26 Cr.
Total Cash from Financing Activities39.50 Cr.37.66 Cr.28.57 Cr.17.32 Cr.
Other Liabilities8.30 Cr.5.68 Cr.-13.50 Cr.9.74 Cr.
Total Assets12.51 Cr.10.44 Cr.19.43 Cr.24.82 Cr.
Net Income-44.52 Cr.-28.35 Cr.-28.87 Cr.-20.01 Cr.
Change in Cash-61.01 Lakhs53.64 Lakhs-17.14 Cr.16.90 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities-17.21 Cr.-14.57 Cr.-35.49 Cr.3.89 Cr.
Depreciation6.29 Cr.4.86 Cr.4.41 Cr.4.18 Cr.
Other Cashflows from Investing Activities4.17 Cr.2.95 Cr.-81.11 Lakhs88.55 Lakhs
Dividends Paid0000
Change to Inventory-8.96 Cr.-1.60 Cr.-6.03 Cr.2.76 Cr.
Change to Account Receivables-57.67 Lakhs-9.77 Lakhs2.70 Cr.-2.58 Cr.
Other Cashflows from Financing Activities-5.39 Cr.-6.27 Cr.-5.92 Cr.-6.23 Cr.
Change to Net Income5.11 Cr.6.55 Cr.4.27 Cr.5.79 Cr.
Capital Expenditures-27.07 Cr.-25.50 Cr.-9.41 Cr.-4.33 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax-44.52 Cr.-28.35 Cr.-28.87 Cr.-20.01 Cr.
Minority InterestNoneNoneNoneNone
Net Income-39.13 Cr.-22.15 Cr.-23.13 Cr.-13.90 Cr.
Selling General Administrative15.30 Cr.16.77 Cr.15.97 Cr.15.80 Cr.
Gross Profit-13.99 Cr.1.08 Cr.9.49 Lakhs8.33 Cr.
Ebit-39.13 Cr.-22.15 Cr.-23.13 Cr.-13.90 Cr.
Operating Income-39.13 Cr.-22.15 Cr.-23.13 Cr.-13.90 Cr.
Other Operating Expenses3.54 Cr.1.25 Cr.2.57 Cr.2.01 Cr.
Interest Expense-5.39 Cr.-6.27 Cr.-5.99 Cr.-6.27 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense0000
Total Revenue59.70 Cr.52.68 Cr.32.39 Cr.46.74 Cr.
Total Operating Expenses98.83 Cr.74.83 Cr.55.53 Cr.60.64 Cr.
Cost of Revenue73.70 Cr.51.59 Cr.32.30 Cr.38.41 Cr.
Total Other Income Expense Net-5.39 Cr.-6.20 Cr.-5.73 Cr.-6.10 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.-44.52 Cr.-28.35 Cr.-28.87 Cr.-20.01 Cr.
Net Income Applicable to Common Shares-44.52 Cr.-28.35 Cr.-28.87 Cr.-20.01 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets1.84 Cr.1.84 Cr.1.84 Cr.1.84 Cr.
Capital Surplus0103.27 Cr.90.96 Cr.80.54 Cr.
Total Liabilities264.89 Cr.201.95 Cr.158.79 Cr.156.65 Cr.
Stock Holder Equity-75.09 Cr.-42.73 Cr.-24.99 Cr.-14.28 Cr.
Minority Interest0000
Other Liabilities29 Cr.7.04 Cr.8.68 Cr.8.30 Cr.
Total Assets189.80 Cr.159.22 Cr.133.80 Cr.142.36 Cr.
Common Stock21.56 Cr.19.62 Cr.18 Cr.16.63 Cr.
Retained Earnings0-181.24 Cr.-153.05 Cr.-122.92 Cr.
Other Liabilities53.90 Cr.53.21 Cr.50.15 Cr.51.56 Cr.
Good Will0000
Treasury Stock-96.65 Cr.15.61 Cr.19.09 Cr.11.45 Cr.
Other Assets8.24 Cr.9.60 Cr.7.38 Cr.8.82 Cr.
Cash10.06 Lakhs71.07 Lakhs17.43 Lakhs17.31 Cr.
Current Liabilities78.06 Cr.48.19 Cr.43.13 Cr.54.86 Cr.
Long Term Asset Charges0000
Short Long Term Debt059.18 Lakhs70.68 Lakhs3.15 Cr.
Other Stockholder Equity-96.65 Cr.15.61 Cr.19.09 Cr.11.45 Cr.
Property Plant Equipment144.21 Cr.126.35 Cr.105.71 Cr.100.71 Cr.
Total Cur. Assets35.49 Cr.21.41 Cr.18.85 Cr.30.97 Cr.
Long Term Investments0000
Net Tangible Assets-76.94 Cr.-44.58 Cr.-26.84 Cr.-16.13 Cr.
Short Term Investments0000
Net Receivables87.65 Lakhs37.64 Lakhs27.38 Lakhs2.98 Cr.
Long Term Debt132.93 Cr.100.54 Cr.65.50 Cr.50.22 Cr.
Inventory25.56 Cr.16.89 Cr.15.38 Cr.9.24 Cr.
Accounts Payable37.90 Cr.17.24 Cr.20.03 Cr.18.64 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account